- Home
- TEVA vs LII Comparison
TEVA vs LII Comparison
Compare TEVA & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- LII
- Stock Information
- Founded
- TEVA 1901
- LII 1895
- Country
- TEVA Israel
- LII United States
- Employees
- TEVA N/A
- LII N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- LII Industrial Machinery/Components
- Sector
- TEVA Health Care
- LII Industrials
- Exchange
- TEVA Nasdaq
- LII Nasdaq
- Market Cap
- TEVA 21.2B
- LII 17.4B
- IPO Year
- TEVA N/A
- LII 1999
- Fundamental
- Price
- TEVA $23.97
- LII $492.22
- Analyst Decision
- TEVA Strong Buy
- LII Hold
- Analyst Count
- TEVA 7
- LII 11
- Target Price
- TEVA $25.86
- LII $607.00
- AVG Volume (30 Days)
- TEVA 12.1M
- LII 555.9K
- Earning Date
- TEVA 11-05-2025
- LII 10-22-2025
- Dividend Yield
- TEVA N/A
- LII 1.06%
- EPS Growth
- TEVA N/A
- LII 12.46
- EPS
- TEVA 0.62
- LII 23.67
- Revenue
- TEVA $16,776,000,000.00
- LII $5,345,300,000.00
- Revenue This Year
- TEVA $4.11
- LII N/A
- Revenue Next Year
- TEVA $0.40
- LII $7.61
- P/E Ratio
- TEVA $38.84
- LII $20.80
- Revenue Growth
- TEVA 0.02
- LII 3.77
- 52 Week Low
- TEVA $12.47
- LII $479.40
- 52 Week High
- TEVA $25.00
- LII $689.44
- Technical
- Relative Strength Index (RSI)
- TEVA 76.02
- LII 39.94
- Support Level
- TEVA $20.11
- LII $481.07
- Resistance Level
- TEVA $25.00
- LII $495.09
- Average True Range (ATR)
- TEVA 0.70
- LII 19.86
- MACD
- TEVA 0.50
- LII -0.06
- Stochastic Oscillator
- TEVA 83.00
- LII 14.45
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.